![Pasi Jänkälä](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Origen de la red de primer grado Pasi Jänkälä.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
ICECAPITAL REAM Oy
![]() ICECAPITAL REAM Oy Investment ManagersFinance ICECAPITAL REAM Oy (ICECAPITAL REAM) is a private equity firm headquartered in Helsinki, Finland. The firm was founded in 2006.
7
| Subsidiary | Investment Managers | 7 |
Bio Fund Management Oy
![]() Bio Fund Management Oy Investment ManagersFinance BioFund Management Oy is a venture capital and private equity investment firm headquartered in Helsinki with an office in Turku and a subsidiary in Copenhagen. BioFund was founded in 1997 by Dr. Kalevi Kurkijärvi, Seppo Mäkinen and Dr. Timo Petäjä. BioFund's main investors are institutions in Finland such as insurance firms, pension funds, foundations, and the European Investment Fund. The firm manages venture capital funds.
1
| Extinct | Investment Managers | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Pasi Jänkälä a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Biketex Ltd. | Chief Executive Officer | ||
Pharmacia Diagnostics Production Oy | Chief Executive Officer | ||
Idea Development ID Oy
![]() Idea Development ID Oy Advertising/Marketing ServicesCommercial Services Idea Development ID Oy is an advertising agency based in Helsinki, Finland. The Finnish company operates as an advertising agency. | Advertising/Marketing Services | Chairman | |
Suomen Itsenäisyyden Juhlarahasto
![]() Suomen Itsenäisyyden Juhlarahasto Investment ManagersFinance Suomen Itsenäisyyden Juhlarahasto is a Finnish innovation fund directly under the Finnish parliament. It primarily invests in foreign and national funds while making selected follow-up investments in Finnish start-ups and later-stage companies. It can consider investing in foreign companies if it is purposeful for the fund's goals. Its investment focus is in the well-being of the Finnish people, environment, and the economy. The size of its initial venture is up to EUR 2 million and its average investment period per company is from 4 to 10 years. | Investment Managers | Director/Board Member | |
Phadia AB
![]() Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Medical Specialties | Chief Executive Officer | |
Curium Finland Oy
![]() Curium Finland Oy Miscellaneous Commercial ServicesCommercial Services MAP Medical Technologies Oy engages in the development and manufacture of radiopharmaceuticals and radiochemical products. It provides positron-emission tomography diagnostic agents and single-photon emission computed tomography products. The company was founded by Mika Nyyssönen and Jarmo Haukka on March 13, 1991 and is headquartered in Tikkakoski, Finland. | Miscellaneous Commercial Services | Chairman | |
Wallac Oy | Corporate Officer/Principal | ||
Bio Orbit Oy | Chairman | ||
BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Chairman | |
FIBROGEN, INC. | Pharmaceuticals: Major | Director/Board Member | |
Ark Therapeutics Oy | Director/Board Member | ||
Innomedica Oy
![]() Innomedica Oy Miscellaneous Commercial ServicesCommercial Services Innomedica is an international business consulting company serving the biotechnology and pharmaceutical industries. It provides a range of professional business development and project management services to its clients in both the public and private sectors. Innomedica's service portfolio includes Business Development, Licensing & Partnering, Japan Markets and Project Management. It is active on a global basis, though it specializes in the North European and Japanese markets. Its people are its main asset. Its success is based on leveraging the experience of professionals from different disciplines to deliver value to its clients. Its team portrays backgrounds from experienced business people to skilled lawyers and biomedical scientists. Innomedica was founded in 1997, and is a privately held company. Its client base covers both private and public sectors, both large and small. | Miscellaneous Commercial Services | Chief Executive Officer | |
Hytest Oy
![]() Hytest Oy BiotechnologyHealth Technology Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland. | Biotechnology | Chairman | |
Fibrogen Europe Oy
![]() Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland. | Biotechnology | Chief Executive Officer | |
Hormos Medical Oy
![]() Hormos Medical Oy Pharmaceuticals: MajorHealth Technology Hormos Medical Oy discovers and develops novel hormonal therapies. It provides research and development of products to treat endocrine disorders associated with aging. The company was founded by Risto Arvo Sakari Lammintausta and Lauri Kangas in 1997 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Chairman | |
University of Turku | College/University | Doctorate Degree | |
Takara Bio Europe AB
![]() Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Stick Tech Oy
![]() Stick Tech Oy Medical SpecialtiesHealth Technology Stick Tech Oy engages in the development, manufacture, and marketing of products for dental reinforcements. It offers everStickC&B, a glass fibre reinforcement for minimally invasive composite bridges. The company was founded in 1997 and is headquartered in Turku, Finland. | Medical Specialties | Chairman | |
Taaleri Pääomarahastot Oy
![]() Taaleri Pääomarahastot Oy Investment ManagersFinance Taaleri Pääomarahastot Oy (Taaleri Pääomarahastot) is a private equity subsidiary of Taaleri Varainhoito Oy founded in 2009. The firm is headquartered in Helsinki, Finland. | Investment Managers | Private Equity Investor |
Estadísticas
Internacional
Finlandia | 17 |
Estados Unidos | 3 |
Suecia | 3 |
Reino Unido | 2 |
Sectorial
Health Technology | 9 |
Commercial Services | 6 |
Finance | 3 |
Consumer Services | 2 |
Operativa
Chairman | 10 |
Director/Board Member | 8 |
Private Equity Investor | 8 |
Chief Executive Officer | 7 |
President | 2 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Pasi Jänkälä
- Conexiones Empresas